# Human Immune Monitoring

> **NIH NIH P30** · STANFORD UNIVERSITY · 2023 · $49,561

## Abstract

PROJECT SUMMARY
The Human Immune Monitoring Shared Resource (HIMC-SR) is focused on state-of-the-art immunological
assays to discover biomarkers of immune competence, diagnosis, prognosis, and response to therapy or
vaccination. The HIMC-SR has two major scientific aims: (1) to provide standardized, comprehensive immune
monitoring services at the RNA, protein, and cellular levels and (2) to offer immunological data analysis and
consultation services.
The HIMC-SR began as a Stanford service center in 2007 and has grown to one of the five largest service
centers in the School of Medicine. Technology platforms have expanded to include multiple innovative mass
cytometry (CyTOF) panels, highly multiplexed immunoassays using Luminex and Olink platforms, and single-
cell genomics assays, including new BD Rhapsody massively parallel single-cell transcriptomics assays, which
now include nucleic acid-tagged antibodies (AbSeq), T cell receptor targeting (TCRseq), and multiplexed sample
tagging. The HIMC-SR has recently developed novel statistical approaches to address the analysis of the large
data sets generated by our assays and their unique characteristics and data structures that need to be
addressed. These new tools include an R utility to correct for batch effects and non-specific binding in Luminex
assays and a star plot visualization for high-dimensional data such as CyTOF. In 2020, 38% of users were SCI
investigators. Members of all programs regularly use the HIMC-SR, with the heaviest use coming from the
Cancer Immunotherapy and Hematologic Malignancies programs. The HIMC-SR contributed to 18 cancer-
focused publications (5 high-impact). The annual budget of the HIMC-SR is $2,238,919, yet the CCSG request
is $57,355. Accordingly, the HIMC-SR leverages extensive institutional support and seeks only 3% from CCSG
funds. Future goals of the HIMC-SR include expansion of large-scale single-cell genomics assays on the BD
Rhapsody platform; continued development of CyTOF panels to include more channels and new markers, as
well as novel quality control measures; development of additional statistical tools and expansion of the Statistical
Consulting Service; and further development of the Stanford Data Miner online database to facilitate data
integration and retrieval.

## Key facts

- **NIH application ID:** 10626983
- **Project number:** 5P30CA124435-15
- **Recipient organization:** STANFORD UNIVERSITY
- **Principal Investigator:** Holden T. Maecker
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $49,561
- **Award type:** 5
- **Project period:** 2007-06-04 → 2027-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10626983

## Citation

> US National Institutes of Health, RePORTER application 10626983, Human Immune Monitoring (5P30CA124435-15). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10626983. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*